Detalhe da pesquisa
1.
Efficacy of prophylactic antibiotics for the prevention of neutropenic fever in patients with multiple myeloma receiving high-dose cyclophosphamide for stem cell mobilization.
Ann Hematol
; 103(5): 1601-1611, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38267561
2.
On-demand plerixafor added to high-dose cyclophosphamide and pegylated recombinant human granulocyte colony-stimulating factor in the mobilization of patients with multiple myeloma: a treatment with high effectiveness, convenient, and affordable cost.
Front Oncol
; 13: 1306367, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38298443
3.
Differentiation induction enhances bortezomib efficacy and overcomes drug resistance in multiple myeloma.
Biochem Biophys Res Commun
; 420(3): 644-50, 2012 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-22450313
4.
[The efficacy and safety of bortezomib-based induction regimen before autologous hematopoietic stem cell transplantation in patients with multiple myeloma].
Zhonghua Nei Ke Za Zhi
; 51(4): 279-83, 2012 Apr.
Artigo
em Zh
| MEDLINE | ID: mdl-22781947
5.
[The clinical features of infection in multiple myeloma undergoing autologous hematopoietic stem cell transplantation].
Zhonghua Nei Ke Za Zhi
; 50(1): 44-7, 2011 Jan.
Artigo
em Zh
| MEDLINE | ID: mdl-21418888
6.
[Maintenance therapies of thalidomine and interferon-α in multiple myeloma].
Zhonghua Yi Xue Za Zhi
; 91(48): 3417-20, 2011 Dec 27.
Artigo
em Zh
| MEDLINE | ID: mdl-22333255
7.
[The clinical features and risk factors for invasive fungal infection in multiple myeloma.].
Zhonghua Nei Ke Za Zhi
; 48(12): 1026-30, 2009 Dec.
Artigo
em Zh
| MEDLINE | ID: mdl-20193522
8.
[The clinical features, chemotherapy responses and survival of 223 patients with newly diagnosed multiple myeloma].
Zhonghua Yi Xue Za Zhi
; 88(30): 2140-3, 2008 Aug 05.
Artigo
em Zh
| MEDLINE | ID: mdl-19080477
9.
Sequential treatment with bortezomib plus dexamethasone followed by autologous hematopoietic stem cell transplantation in patients with multiple myeloma.
Chin Med J (Engl)
; 125(24): 4454-9, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23253719
10.
[BAFF level in bone marrow and expression of BAFF receptor on B cells in multiple myeloma patients].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 20(5): 1131-4, 2012 Oct.
Artigo
em Zh
| MEDLINE | ID: mdl-23114133
11.
[Combination of bortezomib and dexamethasone for newly diagnosed multiple myeloma].
Zhonghua Xue Ye Xue Za Zhi
; 30(8): 543-7, 2009 Aug.
Artigo
em Zh
| MEDLINE | ID: mdl-19954643
12.
[Imatinib induces c-kit positive myeloma cells apoptosis].
Zhonghua Xue Ye Xue Za Zhi
; 29(4): 230-3, 2008 Apr.
Artigo
em Zh
| MEDLINE | ID: mdl-18843975
13.
[Efficacy of bortezomib combined dexamethasone in 24 patients with multiple myeloma].
Ai Zheng
; 27(4): 429-34, 2008 Apr.
Artigo
em Zh
| MEDLINE | ID: mdl-18423132
14.
[Expression and clinical significance of beta-catenin in multiple myeloma].
Ai Zheng
; 26(9): 1010-4, 2007 Sep.
Artigo
em Zh
| MEDLINE | ID: mdl-17927863
15.
[Effect of silencing survivin gene on sensitivity of myeloma cells to adriamycin].
Ai Zheng
; 25(12): 1488-92, 2006 Dec.
Artigo
em Zh
| MEDLINE | ID: mdl-17166372
16.
[Expression and clinical significance of survivin in bone marrow cells of multiple myeloma patients].
Ai Zheng
; 24(12): 1522-6, 2005 Dec.
Artigo
em Zh
| MEDLINE | ID: mdl-16351806